Drugs / EXE844
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT02539654 | Nov 2015 → Jun 2016 | otitis media with effusion | Alcon Research | Completed | No outcome recorded |
| Phase 32 trials | ||||||
| Phase 3 | NCT02432105 | Jun 2015 → Jun 2016 | otitis media with effusion | Alcon Research | Completed | No outcome recorded |
| Phase 3 | NCT02436304 | Jun 2015 → Aug 2016 | otitis media with effusion | Alcon Research | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | EXE844 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02432105 ↗ |
| Route | Other | “ototopical” NCT02432105 ↗ |